Leef Brands (LEEEF) Operating Expenses (2025 - 2026)
Leef Brands (LEEEF) reported Operating Expenses of $3.3 million for Q1 2026, down 16.07% on a YoY basis from $4.0 million in Q1 2025, and down 16.07% sequentially from $4.0 million in Q1 2025.
Leef Brands (LEEEF) Operating Expenses (2025 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 2 years of Operating Expenses data on file, last reported at $3.3 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses fell 16.07% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (changed N/A YoY), and the FY2025 full-year result was $18.1 million, up 15.36% from the prior year.
- Operating Expenses fell to $3.3 million in Q1 2026, from $4.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $4.0 million in Q1 2025 to a low of $3.3 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.34 Mn |
| Mar 31, 2025 | 3.98 Mn |